Everence Capital Management’s Kailera Therapeutics KLRA Stock Holding History
Bought
Maintained
Sold
Other funds holding KLRA
Everence Capital Management's KLRA Position: Q3 2026 in Review
Everence Capital Management opened a new position in Kailera Therapeutics (KLRA) in Q3 2026: 51,340 shares worth $586K. The stake represents 0.03% of the portfolio and ranks #352 among its holdings.
129 funds tracked by Wall St. Rank hold KLRA as of Q3 2026.
- Everence Capital Management held 51,340 shares of Kailera Therapeutics worth $586K as of Q3 2026.
- Kailera Therapeutics was a new Everence Capital Management position in Q3 2026.
- Kailera Therapeutics made up 0.03% of Everence Capital Management's portfolio in Q3 2026, its #352 holding.
- 129 funds tracked by Wall St. Rank held Kailera Therapeutics as of Q3 2026.
Based on Everence Capital Management's 13F filing for Q3 2026, filed 3 Nov 2026.